CXI Healthcare Technology Group Limited (KOSDAQ:900120)

South Korea · Delayed Price · Currency is KRW

869.00

+4.00 (0.46%)

At close: Jul 31, 2026

KOSDAQ:900120 Financials Overview

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	51,446	57,636	69,420	71,617	101,376	104,593
Revenue Growth	-20.11%	-16.97%	-3.07%	-29.35%	-3.08%	64.96%
Gross Profit	14,311	17,316	29,876	28,213	28,358	21,816
Operating Income	6,355	9,700	18,653	7,136	6,292	4,529
Net Income	8,651	12,741	29,349	7,528	5,981	5,098
Earnings Per Share	258.67	21450.03	58000.07	3069.47	2400.00	2291.11
EPS Growth	-76.89%	-63.02%	1789.58%	27.89%	4.75%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	47,082	200,534	159,913	94,625	65,715	25,811
Total Debt	832.28	630.37	187.49	967.18	310.53	878.96
Net Cash (Debt)	46,250	199,903	159,726	93,657	65,404	24,932
Net Cash Growth	-77.77%	25.15%	70.54%	43.20%	162.33%	-88.23%
Net Cash Per Share	1382.92	336554.85	315653.90	38188.48	26668.27	11204.80

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	35,466	40,236	43,666	31,597	35,984	8,723
Capital Expenditures	-223,438	-55.92	-	-	-5.78	-204,888
Free Cash Flow	-187,972	40,180	43,666	31,597	35,979	-196,165
Free Cash Flow Growth	-	-7.98%	38.19%	-12.18%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	27.82%	30.04%	43.04%	39.39%	27.97%	20.86%
Operating Margin	12.35%	16.83%	26.87%	9.96%	6.21%	4.33%
Pretax Margin	18.81%	23.88%	42.27%	10.51%	5.90%	4.86%
Profit Margin	16.81%	22.11%	42.28%	10.51%	5.90%	4.87%
FCF Margin	-365.38%	69.71%	62.90%	44.12%	35.49%	-187.55%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	3.36	1.46	0.98	3.53	5.27	7.40
Forward PE	-	3.78	3.78	3.78	3.78	3.78
P/FCF Ratio	-	0.46	0.66	0.84	0.88	-
PS Ratio	0.13	0.32	0.42	0.37	0.31	0.36